Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03578003 · ClinicalTrials.gov registry record · NA
Morning Bright Light to Improve Sleep Quality in Veterans
A NA study of Post Traumatic Stress Disorder and Brain Injuries, Traumatic, sponsored by Portland VA Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT03578003: Recruiting NA study of Post Traumatic Stress Disorder and Brain Injuries, Traumatic, sponsored by Portland VA Medical Center.
NCT03578003 is a NA study of Post Traumatic Stress Disorder and Brain Injuries, Traumatic that is actively recruiting participants, run by Portland VA Medical Center. The registered enrollment target is 200 participants, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03578003, a NA study of Post Traumatic Stress Disorder and Brain Injuries, Traumatic, is actively recruiting participants, sponsored by Portland VA Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditions, but little has been done investigating the utility of MBLT in improving sleep in Veterans with TBI. This proposal aims to determine the effect of MBLT on sleep quality in Veterans with TBI. Veterans with and without TBI will be recruited from the VA Portland Health Care System. Baseline questionnaires and 7 days of actigraphy will be collected prior to engaging in 60 minutes of MBLT daily for 4 weeks, during which actigraphy will also be collected continuously. Post-MBLT questionnaire data will be collected, and follow-up questionnaire data will be collected at 3 months post-MBLT.
Primary Outcome
Measures self-reported insomnia severity; total score range = 0-28 (higher total score = worse insomnia)
Conditions Studied
Interventions
- OTHER Morning Bright Light Therapy
Study Locations (1)
Oregon
- VA Portland Health Care System - Portand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2017-08-02 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT03578003 shows while recruiting
NCT03578003 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 663-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (70% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 1 intervention - of which Morning Bright Light Therapy is the first listed.
NCT03578003 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03578003 about?
NCT03578003 is a clinical study titled "Morning Bright Light to Improve Sleep Quality in Veterans". One of the principal complicating factors associated with traumatic brain injury (TBI) is sleep-wake disturbances (e.g., insomnia, excessive daytime sleepiness, and circadian rhythm sleep disorders). Morning bright light therapy (MBLT) has been shown to improve sleep quality in a variety of conditio...
What is the current status of trial NCT03578003?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2017-08-02. Estimated completion is 2026-12-01.
What conditions does trial NCT03578003 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Brain Injuries, Traumatic.
What interventions are being tested in trial NCT03578003?
The interventions under investigation include: Morning Bright Light Therapy (OTHER).
Who is sponsoring clinical trial NCT03578003?
This trial is sponsored by Portland VA Medical Center, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03578003 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03578003's enrollment target sits among peer trials
200 47th of 262 higher than 207 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI